Results 31 to 40 of about 25,012 (219)

Rapid evidence profile #57: Examining the use of psychedelic-assisted psychotherapy for Veterans

, 2023
An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian provinces and territories,
Jaspal, A, DeMaio, P, Waddell, K, Wilson, MG, Velez, CM   +4 more
core  

Unifying Theories of Psychedelic Drug Effects

Frontiers in Pharmacology, 2018
How do psychedelic drugs produce their characteristic range of acute effects in perception, emotion, cognition, and sense of self? How do these effects relate to the clinical efficacy of psychedelic-assisted therapies?
Link R. Swanson, Link R. Swanson, Link R. Swanson   +2 more
doaj   +1 more source

Microbiome: The Next Frontier in Psychedelic Renaissance

Journal of Xenobiotics, 2023
The psychedelic renaissance has reignited interest in the therapeutic potential of psychedelics for mental health and well-being. An emerging area of interest is the potential modulation of psychedelic effects by the gut microbiome—the ecosystem of ...
Robert B. Kargbo
doaj   +1 more source

Pharmacokinetics and safety of a modified‐release psilocybin formulation: A SAD Phase I trial in normal‐weight and overweight/obese participants

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the safety, tolerability and pharmacokinetics of a novel oral modified‐release psilocybin formulation (REL‐P11) in normal‐weight and overweight/obese healthy adults and to assess its suitability for controlled, subperceptual exposure, in light of emerging evidence supporting serotonergic modulation in metabolic ...
Anna Signor, Stefano Comai, Gianfranco Pasut, Franco Folli, Marco Gentilucci, Negar Gharavi, Sofia Raitsin, Thuy Van Nguyen, Marco Pappagallo, Andrea Mattarei, Paolo L. Manfredi, Sara De Martin   +11 more
wiley   +1 more source

The Psychedelic Experience: A New Perspective, a New Attitude Towards the World [PDF]

This chapter provides a philosophical account of the potential of the psychedelic experience to treat depression. The main thesis is that such a potential lies in the possibility of psychedelics allowing us to experience a world diametrically opposed to ...
Ballesteros, Virginia
core   +1 more source

Psychedelics and sexual functioning: a mixed-methods study

Scientific Reports
Do psychedelics affect sexual functioning postacutely? Anecdotal and qualitative evidence suggests they do, but this has never been formally tested.
Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph M. Peill, Leor Roseman, David J. Nutt, David Erritzoe, Robin Carhart-Harris, Bruna Giribaldi   +8 more
doaj   +1 more source

Evidence in practice: implementing KAT in indigenous health services

Frontiers in Psychiatry
Ketamine-Assisted Therapy (KAT) presents a promising alternative for addressing mental health challenges, particularly in treatment-resistant conditions, yet little exists in the literature guiding its implementation in an Indigenous context, for ...
Jean Jacque Lovely, Hiedi Yardley, Reverdi Darda, Quintina Bearchief-Adolpho, Lisa Kemp, Charlene Brough, Vanessa Doore, Jennifer Kohlhammer, Andrew Charrette   +8 more
doaj   +1 more source

Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD

BMJ Open, 2023
Introduction Psilocybin-assisted therapy has shown significant promise in treating the cluster of mood and anxiety symptoms that comprise post-traumatic stress disorder (PTSD) but has yet to be tested specifically in this condition.
Alan K Davis, Adam W Levin, Paul B Nagib, Stacey B Armstrong, Rafaelle L Lancelotta   +4 more
doaj   +1 more source

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Eating disorders (EDs) are characterized by high rates of psychiatric comorbidity and suboptimal treatment outcomes. There remain critical gaps in research, including the exploration of effective transdiagnostic interventions. This forum article examines the potential of psilocybin treatment (PT) as a transdiagnostic intervention for
Elena Koning, Jérémie Richard, Aaron Keshen   +2 more
wiley   +1 more source

Further education in psychedelic-assisted therapy – experiences from Switzerland

BMC Medical Education
The growing interest in psychedelic-assisted therapy (PAT) for treating psychiatric disorders such as treatment-resistant depression, PTSD, and anxiety has led to an increasing demand for specialized training.
H.D. Aicher, F. Müller, P. Gasser
doaj   +1 more source